Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer

TNM stage still serves as the best prognostic marker in gastric cancer (GC). The next step is to find prognostic biomarkers that detect subgroups with different prognoses in the same TNM stage. In this study, the expression levels of epidermal growth factor receptor (EGFR) and cyclin D1 were assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Se-Il, Ko, Gyung Hyuck, Lee, Won Sup, Lee, Jeong-Hee, Jeong, Sang-Ho, Lee, Young-Joon, Hong, Soon Chan, Ha, Woo Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947299/
https://www.ncbi.nlm.nih.gov/pubmed/35723316
http://dx.doi.org/10.3390/cimb44030093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947299/
https://www.ncbi.nlm.nih.gov/pubmed/35723316
http://dx.doi.org/10.3390/cimb44030093

Ejemplares similares